Lixin Lang
National Institutes of Health(US)National Institute of Biomedical Imaging and Bioengineering(US)National Institutes of Health Clinical Center(US)
Publications by Year
Research Areas
Radiopharmaceutical Chemistry and Applications, Medical Imaging Techniques and Applications, Cell Adhesion Molecules Research, Peptidase Inhibition and Analysis, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial(2017)4,261 cited
- → Albumin/vaccine nanocomplexes that assemble in vivo for combination cancer immunotherapy(2017)311 cited
- → Development of a Controlled Vocabulary and Software Application to Analyze Fruit Shape Variation in Tomato and Other Plant Species(2006)241 cited
- → Phase I/II safety and antitumor activity of nivolumab in patients with advanced hepatocellular carcinoma (HCC): CA209-040.(2015)196 cited
- → First Experience of 18F-Alfatide in Lung Cancer Patients Using a New Lyophilized Kit for Rapid Radiofluorination(2013)167 cited
- → Tumor mutational burden predicts the efficacy of pembrolizumab monotherapy: a pan-tumor retrospective analysis of participants with advanced solid tumors